FindTrial
Sign In

Effect of a Behavioral Therapy in Reducing Adverse Treatment Outcomes in TB patients who are Alcoholic

Motivational Enhancement Therapy to Reduce Adverse Treatment Outcomes (Default, Death and Failure)among TB Patients having Alcohol Abuse under Programmatic Settings: a randomized control trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051559
Enrollment
600
Registered
2023-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A19- Miliary tuberculosis Health Condition 2: A15- Respiratory tuberculosis Health Condition 3: A17- Tuberculosis of nervous system Health Condition 4: A18- Tuberculosis of other organs

Interventions

Intervention1: Motivational Enhancement Therapy for Alcoholic Patients: Motivational Enhancement Therapy is a counselling technique whose primary goal of MET is to help individuals overcome their inde

Sponsors

ICMR-National JALMA Institute for Leprosy and Other Mycobacterial Diseases
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: NewTB patients having addiction of alcohol Patients ready to give informedwrittenconsent

Exclusion criteria

Exclusion criteria: New TB patients not having addiction of alcohol TB Patients not ready to give informed written consent TB patients less than 14/18 years of age i.e. pediatric age group will be excluded. TB patients more than 65 years of age i.e. geriatric age group will be excluded. TB patients having pre-identified complaints relating to mental retardation or any other severe psychopathology. TB patients having head injury or any severe neurological problem. Multi-Drug Resistant TB patients Pregnant women who have TB will be excluded. Patients who do not take the full course of (12 sessions) of MET therapy would be excluded from the final analysis

Design outcomes

Primary

MeasureTime frame
A new therapy to reduce adverse treatment outcomes among new TB patients under these programmatic settings Timepoint: After 2 years (completion of the project)—

Secondary

MeasureTime frame
Reduction in Adverse Treatment outcomes among the alcoholics on treatment for TuberculosisTimepoint: After 2 years. At the end of the project—

Countries

India

Contacts

Public ContactDr Avi Kumar Bansal

NJIL and OMD Agra

bansalavikumar@gmail.com9012175175

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026